Mutations occurring in GBM are frequently enriched in the extracellular ligand-binding region; for example, the EGFRvIII mutation causing the loss of exons 2 to 7, indicating that sustained downstream signaling caused by ligand-independent EGFR activation may be involved in the pathogenesis of GBM. Here, EGFR is linked to glioblastoma.